Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions

Respirology

Volumn 15, Issue 1, 2010, Pages 115-118

  Neto, Jose D A ^b   De Oliveira, Sandro F Q ^b   Vianna, Sylvana P ^b   Terra, Ricardo M ^a,c  

^a Department of Thoracic Surgery of Hospital Aristides Maltez ^*  (Brazil)

^b Liga Bahiana Contra o Cancer   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Efficacy; Iodopovidone; Malignant pleural effusion; Pleurodesis; Safety

Indexed keywords

LIDOCAINE; POVIDONE IODINE; SODIUM CHLORIDE;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; EMPYEMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; THORAX PAIN;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRAINAGE; EMPYEMA, PLEURAL; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; POVIDONE-IODINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 74049157645     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01663.x     Document Type: Article

References (17)

1. Vaz MC, Marchi E, Vargas FS. Pleurodesis: technique and indications. J. Bras. Pneumol. 2006 32 : 347 356.
2. Olivares-Torres CA, Laniado-Laborýn R, Chávez-Garcýa C et al. Iodopovidine pleurodesis for recurrent pleural effusions. Chest 2002 122 : 581 583.
3. Werebe EC, Pazzeti R, Milanez de Campos JR et al. Systemic distribution of talc after pleural administration in rats. Chest 1999 115 : 190 193.
4. Campos JR, Werebe EC, Vargas FS et al. Respiratory failure due to insufflated talc. Lancet 1997 349 : 251 252.
5. Kuzniar TJ, Blum MG, Kasibowska-Kuzniar K et al. Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis. Ann. Thorac. Surg. 2006 82 : 1976 1981.
6. Janssen JP, Collier G, Astoul P et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007 369 : 1535 1539.
7. Kelly-Garcia J, Roman-Berumen JF, Ibarra-Perez C. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms. Arch. Med. Res. 1997 28 : 583 585.
8. Agarwal R, Aggarwal AN, Gupta D. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy. Respirology 2006 11 : 105 108.
9. Agarwal R, Aggarwal AN, Gupta D et al. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir. Med. 2006 100 : 2043 2047.
10. Caglayan B, Torun E, Turan D et al. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube. Ann. Surg. Oncol. 2008 15 : 2594 2599.
11. Dikensoy O, Light RW. Alternative widely available, inexpensive agents for pleurodesis. Curr. Opin. Pulm. Med. 2005 11 : 340 344.
12. Wagenfeld L, Zeitz O, Richard G. Visual loss after povidine-iodine pleurodesis. N. Engl. J. Med. 2007 357 : 1264 1265.
13. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994 106 : 1215 1222.
14. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann. Intern. Med. 1994 120 : 56 64.
15. Vargas FS, Teixeira LR, Antonangelo L et al. Experimental pleurodesis in rabbits induced by silver nitrate or talc. Chest 2001 119 : 1516 1520.
16. Paschoalini MD, Vargas FS, Marchi E et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest 2005 128 : 684 689.
17. De Campos JR, Vargas FS, Werebe E et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001 119 : 801 806.